DELTEC ASSET MANAGEMENT LLC

Position in JBIO — Jade Biosciences, Inc.

CIK 1269950 New York, NY

Position in JBIO

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$209,667

-$11,704 QoQ

Shares Held

9,436

-40.1% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#106

of 154 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DELTEC ASSET MANAGEMENT LLC holds $932,504 across 4 Biotechnology names. JBIO ranks #3 (22.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PVLA	Palvella Therapeutics, Inc.	2,400	$366,768
2	LSTA	Lisata Therapeutics, Inc.	83,197	$282,869
3	JBIO	Jade Biosciences, Inc. This page	9,436	$209,667
4	PASG	Passage BIO, Inc.	15,000	$73,200

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$209,667	9,436	-40.1%	Shares	Sole	2026-07-21
2026-03-31	$221,371	15,756	0.0%	Shares	Sole	2026-04-24
2025-12-31	$243,115	15,756	0.0%	Shares	Sole	2026-01-29
2025-09-30	$135,974	15,756	0.0%	Shares	Sole	2025-10-24
2025-06-30	$157,402	15,756	—	Shares	Sole	2025-07-18
No filing history on record for this holder in this stock.